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Background: Non-B subtypes account for at least 50 % of HIV-1 infections diagnosed in Belgium and Luxembourg.
They are considered to be acquired through heterosexual contacts and infect primarily individuals of foreign origin.
Information on the extent to which non-B subtypes spread to the local population is incomplete.
Methods: Pol and env gene sequences were collected from 410 non-subtype B infections. Profound subtyping was
performed using 5 subtyping tools and sequences of both pol and env. Demographic information, disease markers
(viral load, CD4 count) and viral characteristics (co-receptor tropism) were compared between subtypes. Maximum
likelihood phylogenetic trees were constructed and examined for clustering.
Results: The majority of non-B infections were diagnosed in patients originating from Africa (55.8 %), individuals
born in Western Europe represented 30.5 %. Heterosexual transmission was the most frequently reported
transmission route (79.9 %), MSM transmission accounted for 12.2 % and was significantly more frequently reported
for Western Europeans (25.7 % versus 4.3 % for individuals originating from other regions; p < 0.001). Subtypes A
and C and the circulating recombinant forms CRF01_AE and CRF02_AG were the most represented and were
included in the comparative analysis. Native Western Europeans were underrepresented for subtype A (14.5 %) and
overrepresented for CRF01_AE (38.6 %). The frequency of MSM transmission was the highest for CRF01_AE (18.2 %)
and the lowest for subtype A (0 %). No differences in age, gender, viral load or CD4 count were observed.
Prevalence of CXCR4-use differed between subtypes but largely depended on the tropism prediction algorithm
applied. Indications for novel intersubtype recombinants were found in 20 patients (6.3 %). Phylogenetic analysis
revealed only few and small clusters of local transmission but could document one cluster of CRF02_AG
transmission among Belgian MSM.
Conclusions: The extent to which non-B subtypes spread in the native Belgian-Luxembourg population is higher
than expected, with 30.5 % of the non-B infections diagnosed in native Western Europeans. These infections
resulted from hetero- as well as homosexual transmission. Introduction of non-B variants in the local high at risk
population of MSM may lead to new sub-epidemics and/or increased genetic variability and is an evolution that
needs to be closely monitored.
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High virus replication rates and error prone reverse
transcription resulted in the genetic diversification of the
main HIV-1 group M into 9 subtypes: A, B, C, D, F, G,
H, J and K [1]. The possibility of recombination further
fuels genetic variability. Amongst the constantly increas-
ing number of circulating recombinant forms (CRF),
CRF01_AE and CRF02_AG have been the most success-
ful (http://www.hiv.lanl.gov/content/sequence/HIV/CRFs/
CRFs.html; last accessed on December 4th 2014) [2]. Be-
tween 2004 and 2007, the subtypes C and A, together with
the recombinants CRF01_AE and CRF02_AG were respon-
sible for 73 % of all infections worldwide [2]. Since the be-
ginning of the HIV epidemic, non-B infections accounted
for up to 50 % of all new diagnoses in Belgium and
Luxembourg [3, 4]. Today, the proportion of non-B infec-
tions in Luxembourg may reach 62 % [5]. Non-B infections
are mainly diagnosed in individuals of foreign origin and in
general acquired through heterosexual contact. This con-
trasts with the epidemic in the local population that is al-
most exclusively driven by men having sex with men
(MSM) infected with subtype B virus. Recent analysis of
transmission dynamics in Luxembourg however provided
evidence for an increasing number of established non-B
transmissions in the country [5]. Subtype specific differ-
ences in disease progression, transmission efficiency or sus-
ceptibility to antiretroviral drugs have been reported but
there still is a lack of consistency in these data [6, 7].
Adequate subtyping is essential when studying the
distribution and characteristics of the different non-B sub-
types. While the initial classification of HIV-1 into subtypes
was based on full length sequences most epidemiological
and clinical studies today, for practical reasons, use partial
sequences for subtyping. Polymerase (pol) gene sequences
are preferably used for that purpose because they are widely
available through routine drug resistance screening and are
considered to contain sufficient phylogenetic signal for sub-
type assignment [8]. Subtype classification based on one
genomic region however, may miss intersubtype recom-
bination [9]. Single region subtyping therefore can intro-
duce bias, especially when studying viral characteristics
not defined by the pol gene such as co-receptor use. The
preference of HIV-1 for one of the two co-receptors,
CCR5 and CXCR4, is determined by a small variable re-
gion (V3) of the envelope (env) gene. The prevalence of
CXCR4-use seems to differ between subtypes with low
CXCR4-use reported for subtype C and high CXCR4-use
for subtype D and CRF01_AE [10–18]. In subtype B, the
ability to use CXCR4 has been associated with faster dis-
ease progression [19, 20]. For the other subtypes, the
potential association between co-receptor use and dis-
ease progression is less well documented.
The study presented here is a retrospective analysis
comparing the characteristics of non-B HIV-1 infectionsin two countries with low HIV prevalence but with a
high diversity of subtypes [3, 4, 21]. Extended subtyping
of 410 non-B infections was performed and patient
demographics, HIV transmission route, co-receptor use,
viral load and CD4 count were compared between sub-
types. The extent to which the non-B subtypes spread
in the native population was defined.
Methods
Patients and sequences
HIV-1 pol sequences (857 nucleotides (nt) long conca-
tenated sequence fragments comprising codon 4 to 99 of
the Protease gene and codon 30 to 226 of the Reverse tran-
scriptase gene), were collected from 410 non-B subtype
HIV-1 infected individuals diagnosed at two sites in
Belgium (Ghent, 277 patients; Antwerp, 82 patients) and
one site in Luxembourg (51 patients) between 2000 and
2012. The pol sequences were obtained as part of routine
clinical care for baseline or pretreatment resistance
analysis. Initial identification of non-B infection was
based on the fast subtyping tool implemented in the
Smartgene IDNS database system (Smartgene IDNS, Zug,
Switzerland). Selected patients had to be treatment naïve
and have sufficient left over plasma available for env se-
quencing. Env sequences were generated following the
procedures for RNA extraction, amplification and Sanger
sequencing as described before [22]. This procedure gen-
erates an amplicon of about 1106 nt long comprising V1
to V4. The short V3 sequence, with a length of
105 nt, could be generated for all 410 samples but se-
quencing of a longer env fragment (of at least 300 nt)
was successful for only 337 samples due to high se-
quence variability and the abundant presence of
indels in this region. Short V3 sequences were used
for co-receptor tropism prediction only, the longer se-
quences were also used for subtype assignment.
Demographic, epidemiological and clinical data were
collected from the patients’ records, including gender,
age, origin, most probable route of transmission, CD4
count and viral load.
Ethics statement
The study was reviewed and approved by the Ethics
Committee of Ghent University Hospital (as central
committee; study number 2011/162), the Institute of
Tropical Medicine Antwerp and the Comité National
d’Ethique pour la Recherche in Luxembourg.
Subtyping
Subtyping was performed using a combination of 5
subtyping tools: Rega v3, http://regatools.med.kuleuven.be/
typing/v3/hiv/typingtool (Rega Institute for Medical Re-
search, Leuven, Belgium) [23]; Comet, http://comet.retro-
virology.lu/ (Laboratory of Retrovirology, Luxembourg
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www.datamonkey.org/dataupload_scueal.php (University of
California San Diego, La Jolla, California, US) [24]; jpHMM,
http://jphmm.gobics.de/submission_hiv (Institute of Micro-
biology and Genetics, University of Göttingen, Germany)
[25] and NCBI, http://www.ncbi.nlm.nih.gov/projects/geno-
typing/formpage.cgi (National Center for Biotechnology
Information, Bethesda, MD) [26]. To classify pol sequences,
Comet and Rega were used initially and the subtype was
attributed in case of concordant results. Sequences with
discordant results or for which the subtype remained un-
assigned by at least one of the two tools were additionally
submitted to SCUEAL and jpHMM. The final subtype was
attributed in case of concordance for at least 3 tools. All
other sequences were considered as unassigned. The same
strategy was used for env subtyping but, given that the
SCUEAL tool can only handle pol sequences it was re-
placed by NCBI.
Genotypic tropism prediction
V3 nucleotide sequences were submitted to geno2phe-
no(co-receptor) (G2P, http://coreceptor.geno2pheno.org, Max
Planck Institute for Informatics, Saarbrücken, Germany)
for co-receptor tropism prediction [27] and interpreted
using the FPR cut off values of 10 and 5.75 %. V3 se-
quences were also submitted to Web PSSM (http://indra.
mullins.microbiol.washington.edu/webpssm/, Department
of Microbiology, University of Washington, Seattle,
Washington, US) [28, 29] and run with the X4/R5 subtype
B matrix and for subtype C also with the subtype C SI/NSI
algorithm. For the subtypes A and C and CRF01_AE and
CRF02_AG additional tropism prediction was performed
with a recently developed subtype specific algorithm,
Phenoseq (http://tools.burnet.edu.au/phenoseq/, Burnet
Institute, Melbourne, Australia) [30].
Phylogenetic analysis
Pol sequences and env sequences >300 bp, were aligned
in the BioEdit Sequence Alignment Editor Version 7.0.9.
For subtype verification, Los Alamos 2010 subtype and
CRF reference sequences with exclusion of the subtype B
and group P references (http://www.hiv.lanl.gov/cgi-bin/
NEWALIGN/align.cgi; last accessed on December 5th
2014) were added to the alignment. For examination of
origin-specific and transmission-route specific clustering
the subtype references were excluded. The HXB2 se-
quence was used as outgroup in all trees. Maximum likeli-
hood trees were generated using the ‘best fit’ evolutionary
model selected by jModeltest version 2.1.7 [31] and the
PhyML software package with approximate likelihood ra-
tio test (aLRT) for branch support [32]. Tree visualization
and editing was done with Itol v2.2.2 [33]. Clusters of
presumed recent transmission were identified with the
automated cluster selection tool developed recently byRagonnet-Cronin et al. [34] using as thresholds aLRT >0.9
and mean genetic distance < 0.045.
Statistical analyses
Statistical analyses were performed using SPSS 22.0 soft-
ware (IBM Corp. Released 2013. IBM SPSS Statistics for
Windows, Version 22.0. Armonk, NY: IBM Corp). Bi-
variate analyses used the chi-square test or Fisher exact
test (if more than 20 % of the cells had expected counts
less than 5) for categorical variables and the Mann–
Whitney U nonparametric test for continuous variables.
The level of significance was set at p < 0.05. P-values
were calculated to assess whether the analyzed parame-
ters showed subtype specific differences. Characteristics




A total of 410 individuals infected with non-B HIV-1 were
selected, 47.3 % were male and the mean age was
33.5 years. Of the 382 individuals with known origin, 213
(55.8 %) were from Africa, 95 (24.9 %) from Belgium or
Luxembourg, 22 (5.6 %) from another Western European
country, 14 (3.7 %) from Eastern Europe, 32 (8.4 %) from
Asia, 5 from South America (1.3 %) and 1 from the
Middle East (0.3 %). Of the 303 infections with known
infection route, heterosexual transmission was the most
frequently reported (242; 79.9 %) followed by MSM trans-
mission (37; 12.2 %), intravenous drug use (IVDU) (10;
3.3 %), blood transfusion (7; 2.3 %) and congenital in-
fection (1; 0.3 %). Multiple risk factors were reported by 6
individuals (2.0 %). Distribution of transmission route for
the 184 individuals born outside of Western Europe was
heterosexual contact (161; 87.5 %), MSM (8; 4.3 %), blood
transfusion (5; 2.7 %), IVDU (5; 2.7 %), congenital trans-
mission (1; 0.5 %) and combined risks (4; 2.2 %). Of the
109 individuals born in Western Europe with known in-
fection route, transmission resulted from heterosexual
contact in 73 (67.0 %), MSM in 28 (25.7 %), IVDU in 5
(4.6 %), blood transfusion in 2 (1.8) and combined risks in
1 (0.9 %). The distribution of MSM and heterosexual
transmission differed significantly between the individ-
uals born in Western Europe and those born elsewhere
(p < 0.001).
Subtyping
Rega and Comet reported a concordant subtype for 351
(85.6 %) of the 410 pol sequences. Ten of the 59 se-
quences with discordant or unassigned subtype could be
attributed to a subtype after consulting jpHMM and
SCUEAL, 49 (11.3 %) remained unassigned. Subtype dis-
tribution was CRF02_AG (100; 27.7 %), A (74; 20.5 %),
CRF01_AE (66; 18.3 %), C (63; 17.5 %), G (29; 8.0 %),
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CRF12_BF (2; 0.6 %), H (1; 0.3 %), CRF03_AB (1; 0.3 %),
CRF11_cpx (1; 0.3 %) and CRF37_cpx (1; 0.3 %). Subtyp-
ing of the 318 env sequences with Rega and Comet
resulted in concordant results for 230 (72.3 %). After con-
sulting jpHMM and NCBI 76 additional sequences were
subtyped, 12 (3.8 %) remained unassigned. Because env
does not allow to reliably discriminate between subtype A
and CRF02_AG, both were classified as ‘A-like’. Final
subtype distribution for the env sequences was A-like
(148; 48.4 %), C (56; 18.3 %), CRF01_AE (54; 17.6 %),
G (21; 6.9 %), B (12; 3.9 %), F (8; 2.6 %), D (6; 2.0 %)
and H (1; 0.3 %).
Concordance between pol and env subtyping
For comparative analysis of the pol and env subtyping, pol
sequences classified as CRF03, CRF06, CRF11, CRF12,
CRF13 and CRF37 were equalized to the subtype that con-
stituted the env region; respectively B, G, A, F, A and A.
Under these conditions, overall concordance between the
pol and the env subtype was 81.1 % (259/318) (Table 1).
Lack of concordance resulted from discordant subtype at-
tribution (n = 24) or failed subtyping for pol (n = 23), env
(n = 4) or both (n = 8). When the 35 subtyping failures
were excluded, overall concordance rose to 91.5 %. Of the
23 samples with unassigned pol but assigned env subtype,
the env classification was A-like for 16 (69.5 %), G for 5
(21.7 %) and B for 2 (8.7 %). Twenty four patients (7.5 %
of those with both pol and env subtype available) showed
evidence of intersubtype recombination. The novel com-
binations were CRF02_AG/G (n = 4), G/B (n = 4), A/B
(n = 3), D/A (n = 3), G/A (n = 2), CRF02_AG/B (n = 2),
CRF01_AE/A (n = 1), CRF01_AE/C (n = 1), CRF02_AG/D
(n = 1), A/C (n = 1), A/G (n = 1) and F/A (n = 1). Nine
of these potential novel recombinants were classified
as subtype B in env. Four were identified as CRF14_BGTable 1 Comparison of the subtypes assigned for the pol and
env sequences
Pol subtype
Env subtype A B C D F G H 01_AE 02_AG UA
A-like 59 3 1 3 1 71 16
B 3 1 4 2 2
C 1 62 1
D 5 1
F 6
G 1 12 5 5
H 1
CRF01AE 57
UA 2 2 8
Concordant subtypes are marked in bold
UA, unassignedafter phylogenetic analysis, 5 were novel non-B/B recombi-
nants. When excluding CRF14_BG, 20 (6.3 %) novel re-
combinants remained with 6 isolated from native Western
Europeans.
Phylogenetic and cluster analysis
Manual examination of the pol phylogenetic tree (Fig. 1)
showed marked subtype specific clustering. A large num-
ber of the pol sequences for which the subtyping tools
failed were localized in the subtype A cluster or in the
CRF02_AG cluster (respectively 16 and 9 of the 49). Se-
quences of individuals with Belgian or Luxembourg origin
were scattered over the tree. They were however in the
majority in the small subtype F cluster. An important rep-
resentation of Western Europeans, mainly originating
from Portugal was also observed for subtype G. In the
large and very branched subtype A cluster, a marked clus-
tering (aLRT = 1.0) of sequences from Eastern Europeans,
many of whom reporting IVDU transmission, was identi-
fied (Fig. 1, cluster 1).
Using stringent cluster selection criteria (aLRT >0.90,
mean genetic distance <0.045 and cluster composed of
at least 3 individuals) the pol tree was further examined
for indications of recent transmission events. Seven
transmission clusters were identified; 5 clusters of 3 indi-
viduals, 1 of 4 individuals and 1 of 6 individuals. Five of
these 7 clusters were also identified in the env tree
(Fig. 2) although for some the env cluster size was
smaller because not all individuals had an env sequence
of >300 bp available. Six of the 7 transmission clusters
resulted from heterosexual transmission. They were
clusters of CRF01_AE (cluster 2 and 3 in Figs. 1 and 2),
subtype A (cluster 4), CRF06_cpx (cluster 5), novel A/B
recombinant (cluster 6) and unassigned sequences (cluster
7). The largest cluster (cluster 8) was a CRF02_AG cluster
of 6 individuals of whom 5 reported MSM as transmission
risk and 5 were of Western European origin.
Subtype related differences in patient demographics, viral
load, CD4 count, co-receptor tropism and transmission
route
To ensure sufficient sample numbers for statistical ana-
lysis, only the subtypes A and C and the CRF01_AE and
CRF02_AG were considered as separate groups, other
subtypes and CRF were pooled and sequences with un-
assigned subtype were excluded. The characteristics of
the patients grouped after pol subtyping are shown in
Table 2. No differences were observed in age or gender
distribution, viral load or CD4 counts. Significant differ-
ences in the origin of patients were recorded: patients
originating from Central and Western Africa and from
Eastern Europe were more frequently infected with sub-
type A, individuals from Western Africa with CRF02_AG,
individuals from Asia with CRF01_AE and individuals
Fig. 1 Maximum likelihood phylogenetic tree of HIV-1 pol sequences. The HXB2 sequence is used as outgroup, aLRT results are shown if they
exceed 0.8. The first characters of the sequence identifier indicate the subtype as assigned by the subtyping tools, the last two characters represent the
patients’ country of origin. Specific clustering is also indicated in the sequence identifier (cluster 1 to 8). A color code next to the sequence identifier
shows the geographical region of origin of the patient, a symbol indicates the transmission route. Geographical region of origin; Central Africa, red;
Eastern Africa, orange; Western Africa, purple; Southern Africa, violet; Northern Africa and the Middle East, brown; Eastern Europe, light blue; Western
Europe except Belgium and Luxembourg, dark blue; Belgium and Luxembourg, green; Asia, yellow; South America and the Caribbean, black. Transmission
route: rectangle, heterosexual contact; triangle, MSM; diamond, IVDU. Country of origin: Angola, AO; Belarus, BY; Belgium, BE; Benin, BJ; Burkina Faso, BF;
Brazil, BR; Burundi, BI; Cambodia, KH; Cameroon, CM; Cape Verde , CV; Congo, CD; Dominican Republic, DO; Eritrea, ER; Ethiopia, ET; France, FR; Gambia,
GM; Ghana, GH; Guinea, GN; India, IN; Indonesia, ID; Iraq, IQ; Italy, IT; Ivory Coast, CI; Kazakhstan, KZ; Kenya, KE. Laos, LA; Liberia, LR; Libya, LY; Luxembourg,
LU; Malawi, MW; Mayotte, YT, Morocco, MA; Mozambique, MZ; Nigeria, NG; Pakistan, PK; Portugal, PT; Russia, RU; Rwanda, RW; Senegal, SN; Sierra Leone,
SL; Slovakia, SK; Sudan, SD; South Africa, ZA; Spain, ES, Swaziland, SZ; Sweden, SE; Thailand, TH; Togo, TG; Chad, TD; Chechnya, RU-CE; Turkey, TR; Uganda,
UG; Ukraine, UA; Zambia, ZM; Zimbabwe, ZW
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Fig. 2 Maximum likelihood phylogenetic tree of HIV-1 env sequences >300 base pairs. The HXB2 sequence is used as outgroup, aLRT results are
shown if they exceed 0.8. The first characters of the sequence identifier indicate the subtype as assigned by the subtyping tools, the last two
characters represent the patients’ country of origin. Specific clustering is also indicated in the sequence identifier (cluster 1 to 8). A color code
next to the sequence identifier shows the geographical region of origin of the patient, a symbol indicates the transmission route. Geographical
region of origin; Central Africa, red; Eastern Africa, orange; Western Africa, purple; Southern Africa, violet; Northern Africa and the Middle East,
brown; Eastern Europe, light blue; Western Europe except Belgium and Luxembourg, dark blue; Belgium and Luxembourg, green; Asia, yellow;
South America and the Caribbean, black. Transmission route: rectangle, heterosexual contact; triangle, MSM; diamond, IVDU. Country of origin:
Angola, AO; Belarus, BY; Belgium, BE; Benin, BJ; Burkina Faso, BF; Brazil, BR; Burundi, BI; Cambodia, KH; Cameroon, CM; Cape Verde , CV; Congo, CD;
Dominican Republic, DO; Eritrea, ER; Ethiopia, ET; France, FR; Gambia, GM; Ghana, GH; Guinea, GN; India, IN; Indonesia, ID; Iraq, IQ; Italy, IT; Ivory
Coast, CI; Kazakhstan, KZ; Kenya, KE. Laos, LA; Liberia, LR; Libya, LY; Luxembourg, LU; Malawi, MW; Mayotte, YT, Morocco, MA; Mozambique, MZ;
Nigeria, NG; Pakistan, PK; Portugal, PT; Russia, RU; Rwanda, RW; Senegal, SN; Sierra Leone, SL; Slovakia, SK; Sudan, SD; South Africa, ZA; Spain, ES,
Swaziland, SZ; Sweden, SE; Thailand, TH; Togo, TG; Chad, TD; Chechnya, RU-CE; Turkey, TR; Uganda, UG; Ukraine, UA; Zambia, ZM; Zimbabwe, ZW
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Table 2 Patient demographics, viral load, CD4 count, co-receptor tropism and transmission route for the most prevalent subtypes and CRF
A (N = 74) C (N = 63) CRF_01AE (N = 66) CRF02_AG (N = 100) Other subtypes and CRF (N = 63) p
Total, N = 366 Count (%) p Count (%) p Count (%) p Count (%) p Count (%) p
Gender, N = 301
Male, N (%) 32 (50) NS 22 (38.6) NS 35 (56.5) 0.089 39 (43.3) NS 13 (46.4) NS NS
Age, N = 347
Median (IQR) 33 (27–40) NS 34 (27–40) NS 34 (27–44) NS 32(28–38) NS 33 (29–40) NS NS
CD4/μl, N = 362
Median (IQR) 351 (240–567) NS 310 (146–310) NS 335 (120–510) NS 335 (222–535) NS 293 (141–571) NS NS
Viral load, N = 363
Median log c/ml (IQR) 4.54 (3.85-5.25) NS 4.35 (3.72-4.86) NS 4.82 (4.22-5.28) 0.045 4.64 (3.88-5.10) NS 4.51 (3.82-5.00) NS NS
Tropisme G2P, N = 366
X4 (G2P 10 %), N(%) 16 (21.6) NS 7 (11.1) 0.014 30 (45.5) <0.001 17 (17.0) 0.097 14 (22.2) NS <0.001
X4 (G2P 5,75 %), N(%) 8 (10.8) NS 3 (4.8) 0.014 24 (36.4) <0.001 9 (9.0) 0.057 10 (15.9) NS <0.001
Tropisme PSSM, N = 360
X4 (PSSM-B), N(%) 12 (16.9) NS 8 (12.7) 0.072 26 (40.0) <0.001 16 (16.3) NS 14 (22.2) NS 0.001
X4 (PSSM-C), N(%) 16 (16,3) NS
Tropisme Phenoseq, N = 277 8 (12.9) 0.021 19 (31.1) NS 13 (21.2) NS 26 (28.0) NS NS
X4, N(%)
Transmission route 0.005
Hetero, N (%) 44 (59.5) NS 37 (58.7) NS 42 (63.6) NS 57 (57.0) NS 39 (61.9) NS
MSM, N (%) 0 (0) 0.003 3 (4.8) NS 12 (18.2) 0.011 11 (11.0) NS 6 (9.5) NS
Other, N (%) 9 (12.2) 0.020 2 (3.2) NS 2 (3.0) NS 4 (4.0) NS 5 (7.9) NS
Unknown, N (%) 21 (28,4) NS 21 (33,3) NS 10 (15,2) 0,034 28 (28,0) NS 13 (20,6) NS
Country of origin, N = 366 <0.001
Europe-West, N (%) 12 (16.2) 0.008 15 (23.8) NS 31 (47.0) 0.001 22 (22.0) 0.053 27 (42.9) 0.016
Europe-East, N (%) 13 (17.6) <0.001 0 (0) NS 0 (0) 0.082 0 (0) 0.014 1 (2.4) NS
Africa-Nord/Middle
East, N (%)
2 (2.7) NS 1 (1.6) NS 0 (0) NS 4 (4.0) NS 1 (1.6) NS
Africa-West, N (%) 10 (13.5) 0.016 1 (1.6) <0.004 2 (3.0) <0.001 58 (58.0) <0.001 20 (31.7) NS
Africa-Central, N (%) 26 (35.1) <0.001 19 (30.2) 0.001 1 (1.5) <0.001 7 (7.0) 0.003 7 (11.1) NS
Africa-East, N (%) 2 (2.7) NS 8 (12.7) 0.002 0 (0) 0.050 2 (2.2) NS 4 (6.3) NS















Table 2 Patient demographics, viral load, CD4 count, co-receptor tropism and transmission route for the most prevalent subtypes and CRF (Continued)
Asia, N (%) 0 (0) 0.004 2 (3.2) NS 29 (43.9) <0.001 0 (0) <0.001 0 (0) 0.007
Latin America, N (%) 0 (0) NS 0 (0) NS 0 (0) NS 1 (1) NS 1 (1.6) NS
Unknown, N (%) 7 (9.5) NS 6 (9.5) NS 3 (4.5) NS 6 (6.0) NS 2 (3.2) NS
Subtype classification based on pol sequences
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Western Europeans accounted for between 16.2 % and
47.0 % of all non-B infections. They were underrepresented
in subtype A (p = 0.008) and overrepresented in CRF01_AE
(p = 0.001) and in the pooled group of other subtypes and
CRFs (p = 0.016). MSM as route of transmission was the
most frequently recorded for CRF01_AE (18.2 %; p = 0.011)
but was never reported for subtype A (0 %; p = 0.003).
IVDU transmission was only reported by patients originat-
ing from Eastern Europe and all but one were subtype A
infections. CXCR4-using viruses were significantly
more prevalent in CRF01_AE (p < 0.001) and less
prevalent in subtype C (p = 0.014) when using G2P or
PSSM but not when using Phenoseq. The Phenoseq
prediction system on the other hand reported a sig-
nificantly lower CXCR4-use prevalence in subtype A
(p = 0.022).
The analysis presented in Table 2 was repeated after
grouping the patients based on env subtyping. The out-
come was comparable (results not shown).
Characteristics of the non-B infections in the native
population
The majority (91.6 %) of the Western-Europeans in the co-
hort were of Belgian or Luxembourg origin. The subtype
distribution amongst this native population was CRF01_AE
(30.6 %), CRF02_AG (19.4 %), C (15.3 %), A (12.2 %),
F (8.2 %), CRF06 (2.0 %), D (1 %), G (1%), H (1 %), and
unassigned (9.2 %). The main infection route was hetero-
sexual (68.1 %) followed by MSM (28.6 %) and blood trans-
fusion (3.3 %).
Discussion
Several Western European countries, especially those
with large sub-Saharan African immigrant communities,
have a high burden of HIV-1 non-B infections. The vast
majority of these infections are acquired through hete-
rosexual contacts. This contrasts with the subtype B
epidemic in the same countries, that is driven predomin-
antly by MSM and affects primarily young white men
[35, 36]. Increasing frequencies of non-B infections over
time have been reported for Belgium [4], Spain [37],
Italy [38], France [39], Sweden [40, 41] and Luxembourg
[21]. Although information on the extent to which the
subtype B and non-B epidemics intermingle remains
limited, ascending prevalence’s of non-B subtypes in na-
tive Europeans have been reported [21, 37, 41].
For this study we selected 3 sites in Belgium and
Luxembourg, two small countries with a high migration
rate, for investigation of the non-B infections. Although
the study is biased by the random selection of non-B in-
fections and the unequal distribution of patients across
the territory and can therefore not be seen as representa-
tive for the general epidemic in these countries, it doesprovide some interesting insights in the dynamics of the
non-B infections. Important strengths of the study are
the large sample size, the high subtype and CRF hetero-
geneity and the availability of both pol and env sequences
for subtype assignment.
A higher than expected percentage of patients with
non-B infections were of Western European origin
(30.7 %; 24.5 % from Belgium or Luxembourg and 5.6 %
from other Western European countries). While hetero-
sexual transmission accounted for the majority (79.3 %)
of infections a significant proportion of the patients
reported MSM transmission (13.3 %). MSM infections
were more frequent in Western Europeans (28.6 % ver-
sus 5.1 % non-Western Europeans; p < 0.001) providing
proof for the spread of non-B subtypes to the native
high-at-risk MSM population. One MSM transmission
cluster of CRF02_AG was identified but this was the
only clear phylogenetic indication of local non-B
transmission in MSM. CRF01_AE was the most repre-
sented non-B subtype in Western Europeans (38.6 %),
followed by CRF02_AG (27.7 %), C (19.3 %) and A
(14.5 %). The higher prevalence of CRF01_AE in indi-
viduals born in Western Europe can have several rea-
sons. The Philippines and Thailand, where CRF01_AE is
the major subtype [42] are in the top 5 of bride-donor-
countries of Belgium (http://www.esf-agentschap.be/sites/
default/files/attachments/articles/eindrapport_partnermi-
gratie.pdf ). Sex tourism to South-East Asia may also have
triggered the presence of CRF01_AE, in heterosexuals as
well as MSM. MSM were significantly more represented
amongst the CRF01_AE infections compared to the other
subtypes. The profound intermingling of the CRF01_AE
sequences from native Western Europeans and Asians and
the lack of clear indications for onward local CRF01_AE
transmission apart from some paired transmissions suggest
that most CRF01_AE infections are imported infections.
Infection through IVDU was reported infrequently and
only in Eastern-European individuals. The phylogenetic
analysis revealed a very close genetic relationship be-
tween the viruses isolated from these Eastern-European
IVDU but no indications for a spread of these particular
strains to the local population.
Weakening of the association between subtypes and
patient origin as well as between subtypes and exposure
group has been reported before for the UK, Spain, Italy
and Sweden [41, 43–46]. Future surveillance of this evo-
lution will be important because this tendency can have
implications on many facets of HIV care and prevention.
Introduction of non-B subtypes in native high-at-risk
populations may increase the overall genetic heterogen-
eity and the frequency of intersubtype recombination.
Recombination may occasionally result in viral variants
with increased pathogenesis as demonstrated recently in
Cuba [47]. In our study, indications for novel intersubtype
Dauwe et al. BMC Infectious Diseases  (2015) 15:524 Page 10 of 12recombination were found in 6.3 % of the patients and a
high contribution of non-B/B recombinants was noticed (5
of the 20 recombinants). This number of novel non-B/B
recombinants is almost certainly an underestimation as
the initial selection of non-B infections was based on the
pol subtype and excluded infections classified as subtype B
in pol. High percentages of novel recombinants have been
reported for Spain (13.4 %) [48], Italy (9.4) [38] and UK
(9.9 %) [49]. In these studies the classification of novel
recombination is based only on the pol sequence. In our
study however, 25 of the 49 pol sequences considered
as having a complex mosaic genetic pattern, were assigned
A-like in env and classified as subtype A by pol phylogen-
etic analysis. Adequate classification of subtype A and
CRF02_AG pol sequences seems particularly challenging
because of the overall high genetic variability within these
subtypes. This apparently may lead to a false identification
of novel recombinants and may partly explain the import-
ant differences in frequency of novel recombination be-
tween studies, a hypothesis that needs to be confirmed.
Local spread of these novel recombinants was still limited,
only one small transmission cluster of a novel A/B recom-
binant was observed.
The patients infected with the most represented sub-
types, A, C, CRF01_AE and CRF02_AG, did not differ in
age, gender or CD4 count. The significant differences in
distribution of patient origin followed the geographic
distribution pattern of the respective subtypes [2].
The higher prevalence of CXCR4-use in CRF01_AE
when using the G2P or PSSM prediction algorithms and
the lower prevalence of CXCR4-use in subtype C con-
firmed previous findings [10, 11, 14, 50, 51]. It is known
however that G2P and PSSM lack accuracy for non-B sub-
types [14, 52, 53]. Recently, an algorithm has been devel-
oped that claims high sensitivity and specificity for the
subtypes A, B, C, D, CRF01_AE and CRF02_AG [30].
When applying this algorithm the prevalences of CXCR4-
use for the subtypes A and CRF01_AE differed consider-
ably from the ones recorded with G2P and PSSM. These
observations show that problems with co-receptor trop-
ism prediction of some non-B subtypes are still unresolved
and that urgent actions for improvements are needed.
We were unable to define subtype related differences
in viral load or CD4 count but have to acknowledge that
it is a shortcoming of this study that viral load and CD4
data were based on single measurement and could not
be corrected for time of infection.
Conclusion
A higher than expected proportion of the non-B infections
sampled in Belgium and Luxembourg were diagnosed in
individuals of Western European origin. The spread of
African and Asian subtypes to the local population re-
sulted from heterosexual as well as MSM transmission.Local spread remains limited. Subtype related differences
in patient origin, infection route and CXCR4-use were no-
ticed but no differences in gender, age, CD4 count or viral
load were found. Future monitoring of the introduction of
non-B infections in the local population is warranted both
from an epidemiological and a prevention perspective.
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